Tutorials › Competing Risks and Multi-State Models › Censoring Assumptions for Causal Risk Estimation

Causal Contrasts With Competing Events · Tutorial 191 of 699

Censoring Assumptions for Causal Risk Estimation

Learn which censoring assumptions let observed follow-up identify treatment-specific cumulative incidence, and why a competing event must remain an observed outcome rather than be treated as loss to follow-up.

Advanced 12 min read

What You'll Learn

  • Distinguish loss to follow-up from a competing event in the observed event process.
  • State conditional independent-censoring and censoring-positivity assumptions.
  • Connect censoring assumptions to treatment-specific cumulative incidence.
  • Derive the discrete-time cumulative-incidence recursion from cause-specific hazards.
  • Recognize informative censoring and understand what diagnostics can and cannot establish.
  • Compare censoring assumptions with the different estimand created by eliminating a competing event.

Why Censoring Needs Its Own Assumptions

A treatment-specific cumulative incidence is the probability that a particular event occurs by a specified time under a specified treatment strategy, while other event types remain possible. In a competing-risks setting, a competing event can make the event of interest impossible to experience first. Loss to follow-up is different: it stops observation, but it does not itself determine what would happen next. Treating these two situations as equivalent changes the risk being estimated.

The issue is identification. When a participant is lost before the end of follow-up, their later event type and event time are unknown. The observed data identify the treatment-specific risk only if the loss process does not selectively hide different future event experiences, after conditioning on the information used to account for censoring. This assumption is separate from the assumptions needed to compare treatments causally.

Definition: Let \(A\) denote treatment, \(L\) measured baseline covariates, \(T\) the time to the first event, and \(J\) its type. Let \(J=1\) denote the event of interest and \(J=2\) a competing event. Let \(C\) denote time to loss of observation, not including a competing event. For a fixed horizon \(\tau\), the treatment-specific cumulative incidence is \(P(T^a\leq \tau,J^a=1)\), where \(T^a,J^a\) are the event time and type that would occur under treatment \(a\).

The superscript \(a\) describes a potential outcome under a treatment strategy. To interpret an observed treatment-specific risk causally, one also needs consistency, treatment exchangeability, and treatment positivity: briefly, the observed outcomes agree with the potential outcomes under the received treatment; treatment assignment is conditionally exchangeable given the measured covariates; and each treatment being compared is possible at each relevant covariate value. The earlier material on consistency and treatment versions, exchangeability, and positivity develops these requirements. This tutorial focuses on the additional requirements created by incomplete follow-up.

Independent Censoring and Censoring Positivity

A simple baseline-covariate version of the independent-censoring condition is that, within treatment and baseline-covariate groups, the censoring time carries no further information about the event time or event type. In notation, a sufficient formulation is conditional independence of \(C\) and the pair \((T,J)\) given \(A,L\). It says that among participants with the same treatment and measured baseline covariates, those still observed at a given time represent those who have been censored with respect to their future event experience.

Assumption: For a chosen horizon \(\tau\), conditional independent censoring requires \(C\perp (T,J)\mid A,L\) over the follow-up interval relevant to estimating risk through \(\tau\). Censoring positivity requires a positive probability of remaining observed through each time needed for that risk, within the treatment and covariate groups being analyzed.

This condition is conditional, not necessarily marginal. If people with different prognoses are more likely to leave follow-up, censoring can be informative overall even when it becomes independent of future event experience after conditioning on measured \(L\). Conversely, adjusting for a covariate does not solve the problem if relevant predictors of both loss and future events are unmeasured, poorly measured, or omitted.

A more general condition is needed when censoring depends on measured information collected during follow-up. At each time, conditional on treatment and the observed history up to that time, remaining uncensored must be independent of the subsequent event process. This is a sequential conditional independence assumption. It is not justified merely because the history is observed; the history must contain the relevant shared predictors of censoring and future events, and there must still be a positive chance of continued observation at the histories being considered.

Censoring positivity is substantive. If everyone in some treatment-covariate group is lost before a time of interest, the data contain no direct information about their event experience after that time. No amount of modeling can recover that part of the risk without additional assumptions. A very small probability of continued observation is also a warning: estimates may depend heavily on a few observed participants.

How the Assumption Connects to Cumulative Incidence

The connection is clearest in discrete time. Consider intervals \(1,\ldots,K\), conditional on a treatment and covariate group. Define \(h_j(k)\) as the probability that event type \(j\) occurs in interval \(k\), conditional on being event-free at its start. The probability of remaining event-free through interval \(k\) is denoted \(S(k)\), with \(S(0)=1\). Loss to follow-up is not an event in these definitions.

$$ S(k)=S(k-1)\{1-h_1(k)-h_2(k)\},\qquad F_1(K)=\sum_{k=1}^{K}S(k-1)h_1(k). $$

Here \(F_1(K)\) is the cumulative incidence of event type 1 by interval \(K\). The formula follows by adding the probability of a type 1 event in each interval: a person must have remained free of both event types through the preceding interval, which has probability \(S(k-1)\), and then experience type 1 in interval \(k\), with conditional probability \(h_1(k)\). The mutually exclusive first-event types imply that the probability of staying event-free over the next interval is \(1-h_1(k)-h_2(k)\).

With censoring, the hazards in this calculation are learned from participants still at risk and observed in each interval. Conditional independent censoring makes their event experience representative of the comparable participants who were censored, conditional on the variables in the assumption. Censoring positivity ensures that there are such observed participants throughout the relevant follow-up. The competing event remains in the event-free survival calculation as a real event type: it reduces the number who can subsequently experience the event of interest.

In a causal analysis, this identifies the event distribution under each treatment only when the censoring conditions are combined with the treatment-assignment assumptions and consistency. The treatment-specific risks can then be related to the target population by accounting for its covariate distribution. The particular procedure for that population aggregation is a separate step; the censoring assumption does not itself remove confounding or define the target population.

Worked Example: Cumulative Incidence With Independent Loss to Follow-Up

Suppose a hypothetical randomized study has no baseline covariates to condition on and compares treatment \(a\). In two successive intervals, the observed cause-specific hazards among participants still event-free and observed are \(h_1(1)=0.10\), \(h_2(1)=0.20\), \(h_1(2)=0.15\), and \(h_2(2)=0.10\). Assume loss to follow-up is conditionally independent of future event time and type given treatment, and that some participants remain observed in both intervals. These assumptions allow the observed hazards to represent the corresponding event hazards in the treatment group.

At the end of interval 1, the event-free probability is

$$ S(1)=1\{1-0.10-0.20\}=0.70. $$

The type 1 cumulative incidence through interval 1 is \(0.10\). The additional type 1 incidence in interval 2 is the probability of reaching that interval event-free multiplied by its type 1 hazard:

$$ S(1)h_1(2)=0.70(0.15)=0.105. $$

Therefore, the cumulative incidence through interval 2 is

$$ F_1(2)=1(0.10)+0.70(0.15)=0.205. $$

The estimated risk is 0.205, or 20.5%, through the two intervals under treatment \(a\). The competing event has not been removed: its first-interval hazard is part of the calculation that leaves 70% event-free for interval 2.

Loss to Follow-Up Is Not a Competing Event

A competing event is observed and determines that the participant has experienced a different first event. For example, if death prevents a later nonfatal event from occurring, death is an outcome type, not a missing outcome. A participant lost to follow-up has no observed event status after the loss time. The distinction matters both for what is recorded and for the probability being estimated.

Worked Example: Why Censoring a Competing Event Changes the Risk

Consider a hypothetical cohort of 100 participants with no loss to follow-up. In interval 1, 10 experience the event of interest, 20 experience a competing event, and 70 remain event-free. In interval 2, 10% of the 70 event-free participants experience the event of interest; assume no other interval-2 events for this calculation.

The actual cumulative incidence through interval 2 is

$$ \frac{10}{100}+\frac{70}{100}(0.10)=0.10+0.07=0.17. $$

Thus 17% experience the event of interest by the end of interval 2. If instead the 20 participants with the competing event were treated as censored and the competing event were eliminated, the first-interval risk among the original 100 is 0.10; the remaining 90 are treated as eligible for the second interval. Applying the stated 10% second-interval hazard gives a hypothetical net risk of

$$ 0.10+(0.90)(0.10)=0.19. $$

The 19% quantity is not the observed cumulative incidence. It corresponds to a different, hypothetical calculation in which the competing event does not remove participants from the possibility of a later event of interest. A competing event cannot be recoded as ordinary loss to follow-up while retaining the original cumulative-incidence interpretation.

The arithmetic in this example depends on the stated interval hazards and is meant to expose the distinction, not to prescribe an estimator. In real data, treating competing events as censoring in a survival calculation generally targets a net risk under a hypothetical removal of competing events, rather than the observed-world cumulative incidence. The treatment-specific cumulative incidence keeps the competing event in the event process.

What Goes Wrong When Censoring Is Informative

Worked Example: Prognosis-Related Loss to Follow-Up

Suppose a hypothetical treatment group contains equal numbers of two types of participants, high-risk and low-risk. By a fixed horizon, their true event-of-interest risks are 0.40 and 0.10, respectively. The target group risk is therefore

$$ 0.50(0.40)+0.50(0.10)=0.25. $$

Suppose only 20% of high-risk participants remain observed through the horizon, compared with 90% of low-risk participants. Among those remaining observed, the high-risk proportion is

$$ \frac{0.50(0.20)}{0.50(0.20)+0.50(0.90)} =\frac{0.10}{0.55}=0.1818. $$

The low-risk proportion among those observed is \(0.8182\). If the observed cases are used as though they represented everyone in the treatment group, the resulting event risk is

$$ 0.1818(0.40)+0.8182(0.10)=0.1545. $$

This 15.45% risk is below the true 25% risk because high-risk participants are underrepresented among those observed. If high-risk status were measured and included in the censoring condition, the analysis could account for the different observation patterns, provided there is still adequate follow-up in both groups. If it were unmeasured, the stated conditional independence assumption would fail.

Diagnostics, Alternatives, and Limits

Censoring assumptions are not proven by a nonsignificant test or by a well-fitting event model. They concern unobserved outcomes after loss, so direct verification is impossible. Useful checks can reveal problems or make an assumption less plausible, but cannot establish independence.

  • Describe when and for whom censoring occurs. Compare censoring proportions and times across treatment groups and measured prognostic covariates. Mark whether losses cluster around particular times or sites.
  • Check follow-up support. Examine the number still observed over time within important treatment and covariate groups. Empty or nearly empty risk sets signal positivity problems and unstable inference.
  • Review the information available at loss. Determine whether recorded health status, contact history, or other predictors of future events also predict loss. Their omission can make conditional independent censoring implausible.
  • Separate administrative end from loss. A study's fixed end date is often set by design, whereas participants may leave early for reasons related to prognosis. The latter requires particular scrutiny. Neither circumstance licenses treating a competing event as censoring.

The most direct alternative to a conditional independent-censoring assumption is not a routine adjustment, but acknowledging that the risk may not be identified from the observed data without further assumptions. Sensitivity analyses can examine how conclusions change under departures from the assumption. If censoring is plausibly independent only after conditioning on measured covariates, an analysis must actually use those covariates in a way appropriate to its estimator; merely stating the condition is not enough. Inverse-probability-of-censoring weighting and outcome-model approaches are distinct estimation strategies, each requiring correctly specified modeling choices and adequate support. They do not make informative censoring harmless by their names.

The central limitation is that independent censoring is an assumption about the relation between observed follow-up and unobserved future outcomes. Diagnostics can identify warning signs, but no observed-data pattern alone proves that people lost to follow-up would have had the same future event distribution as comparable people who remained observed. Likewise, conditional independent censoring does not address unmeasured treatment confounding, treatment positivity failures, incorrect event classification, or a poorly chosen horizon.

Common pitfall: “A competing event prevents the event of interest, so I can censor it just like loss to follow-up.” This reasoning confuses an observed event with missing follow-up. A competing event changes who remains capable of experiencing the event of interest and belongs in the cumulative-incidence calculation. Censoring it instead targets a hypothetical net risk, not the observed-world cumulative incidence.

Check Your Understanding

Answer each question, then compare with the brief solutions below.

  1. In one sentence, distinguish a competing event from loss to follow-up.
  2. What does conditional independent censoring given treatment and baseline covariates assert about participants who are censored?
  3. In a treatment-covariate group, everyone is lost before the horizon \(\tau\). Which censoring condition fails, and why can the risk not be learned directly after that point?
  4. In a single interval, \(h_1=0.08\) and \(h_2=0.12\). What proportion remains event-free at the interval end, and what is the type 1 cumulative incidence for that interval?
  5. Why is a comparison of measured covariates between censored and uncensored participants not proof of independent censoring?

Solutions. (1) A competing event is an observed first event of another type; loss to follow-up ends observation while leaving later event status unknown. (2) Within the specified treatment and covariate group, censoring gives no additional information about future event time or type. (3) Censoring positivity fails: there are no observed participants representing that group after the loss time, so its subsequent event experience is not directly identified. (4) Event-free proportion is \(1-0.08-0.12=0.80\), and the type 1 incidence is \(0.08\). (5) Similarity on measured covariates cannot rule out dependence on unmeasured predictors or on the unobserved future event outcomes themselves.

Clinical Biostats